{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:08:17Z","timestamp":1793912897391,"version":"4.8.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0532-2","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T07:51:34Z","timestamp":1524037894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Potent prion-like behaviors of pathogenic \u03b1-synuclein and evaluation of inactivation methods"],"prefix":"10.1186","volume":"6","author":[{"given":"Airi","family":"Tarutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Hisanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-8159","authenticated-orcid":false,"given":"Masato","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"532_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE et al (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239\u2013252","journal-title":"Neuron"},{"key":"532_CR2","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ et al (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739\u201329752","journal-title":"J Biol Chem"},{"key":"532_CR3","unstructured":"Ayers JI, Brooks MM, Rutherford NJ, Howard JK, Sorrentino ZA, Riffe CJ et al (2017) Robust central nervous system pathology in transgenic mice following peripheral injection of alpha-Synuclein fibrils. J Virol 91"},{"key":"532_CR4","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"532_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","volume":"3","author":"ME Bernis","year":"2015","unstructured":"Bernis ME, Babila JT, Breid S, Wusten KA, Wullner U, Tamguney G (2015) Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol Commun 3:75","journal-title":"Acta Neuropathol Commun"},{"key":"532_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cell.2005.10.017","volume":"123","author":"NM Bonini","year":"2005","unstructured":"Bonini NM, Giasson BI (2005) Snaring the function of alpha-synuclein. Cell 123:359\u2013361","journal-title":"Cell"},{"key":"532_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/JPD-150691","volume":"6","author":"L Bousset","year":"2016","unstructured":"Bousset L, Brundin P, Bockmann A, Meier B, Melki R (2016) An efficient procedure for removal and inactivation of alpha-Synuclein assemblies from laboratory materials. J Parkinsons Dis 6:143\u2013151","journal-title":"J Parkinsons Dis"},{"key":"532_CR8","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B et al (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575","journal-title":"Nat Commun"},{"key":"532_CR9","doi-asserted-by":"publisher","unstructured":"Braak H, Del Tredici K (2016) Potential pathways of abnormal tau and alpha-Synuclein dissemination in sporadic Alzheimer's and Parkinson's diseases. Cold Spring Harb Perspect Biol 8. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a023630","DOI":"10.1101\/cshperspect.a023630"},{"key":"532_CR10","doi-asserted-by":"publisher","first-page":"9182","DOI":"10.1128\/JVI.01399-16","volume":"90","author":"S Breid","year":"2016","unstructured":"Breid S, Bernis ME, Babila JT, Garza MC, Wille H, Tamguney G (2016) Neuroinvasion of alpha-Synuclein Prionoids after intraperitoneal and Intraglossal inoculation. J Virol 90:9182\u20139193","journal-title":"J Virol"},{"key":"532_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18:901\u2013907","journal-title":"Emerg Infect Dis"},{"key":"532_CR12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663\u20131667","journal-title":"Science"},{"key":"532_CR13","doi-asserted-by":"publisher","first-page":"14966","DOI":"10.1073\/pnas.0406283101","volume":"101","author":"S Chandra","year":"2004","unstructured":"Chandra S, Fornai F, Kwon HB, Yazdani U, Atasoy D, Liu X et al (2004) Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A 101:14966\u201314971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0014-5793(98)01146-6","volume":"436","author":"RA Crowther","year":"1998","unstructured":"Crowther RA, Jakes R, Spillantini MG, Goedert M (1998) Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett 436:309\u2013312","journal-title":"FEBS Lett"},{"key":"532_CR15","doi-asserted-by":"publisher","first-page":"12926","DOI":"10.1073\/pnas.0903200106","volume":"106","author":"YS Eisele","year":"2009","unstructured":"Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX et al (2009) Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A 106:12926\u201312931","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0140-6736(04)16810-4","volume":"364","author":"G Fichet","year":"2004","unstructured":"Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A et al (2004) Novel methods for disinfection of prion-contaminated medical devices. Lancet 364:521\u2013526","journal-title":"Lancet"},{"key":"532_CR17","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/brain\/awu255","volume":"137","author":"SK Fritschi","year":"2014","unstructured":"Fritschi SK, Langer F, Kaeser SA, Maia LF, Portelius E, Pinotsi D et al (2014) Highly potent soluble amyloid-beta seeds in human Alzheimer brain but not cerebrospinal fluid. Brain 137:2909\u20132915","journal-title":"Brain"},{"key":"532_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"532_CR19","doi-asserted-by":"publisher","first-page":"e1000206","DOI":"10.1371\/journal.ppat.1000206","volume":"4","author":"K Giles","year":"2008","unstructured":"Giles K, Glidden DV, Beckwith R, Seoanes R, Peretz D, DeArmond SJ et al (2008) Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog 4:e1000206","journal-title":"PLoS Pathog"},{"key":"532_CR20","doi-asserted-by":"publisher","unstructured":"Giles K, Woerman AL, Berry DB, Prusiner SB (2017) Bioassays and inactivation of prions. Cold Spring Harb Perspect Biol 9. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a023499","DOI":"10.1101\/cshperspect.a023499"},{"key":"532_CR21","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M (2015) NEURODEGENERATION. Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 349:1255555","journal-title":"Science"},{"key":"532_CR22","first-page":"S53","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert M, Jakes R, Spillantini MG (2017) The Synucleinopathies: twenty years on. J Parkinsons Dis 7:S53\u2013S71","journal-title":"J Parkinsons Dis"},{"key":"532_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60\u201370","journal-title":"Ann Neurol"},{"key":"532_CR24","doi-asserted-by":"publisher","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM et al (2002) Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem 277:49071\u201349076","journal-title":"J Biol Chem"},{"key":"532_CR25","doi-asserted-by":"publisher","unstructured":"Hasegawa M, Nonaka T, Masuda-Suzukake M (2016) Alpha-Synuclein: experimental pathology. Cold Spring Harb Perspect Med 6. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a024273","DOI":"10.1101\/cshperspect.a024273"},{"key":"532_CR26","doi-asserted-by":"publisher","first-page":"e1005914","DOI":"10.1371\/journal.ppat.1005914","volume":"12","author":"AG Hughson","year":"2016","unstructured":"Hughson AG, Race B, Kraus A, Sangare LR, Robins L, Groveman BR et al (2016) Inactivation of prions and amyloid seeds with Hypochlorous acid. PLoS Pathog 12:e1005914","journal-title":"PLoS Pathog"},{"key":"532_CR27","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 33:1024\u20131037","journal-title":"J Neurosci"},{"key":"532_CR28","volume-title":"Acta Neuropathol","author":"Z Jaunmuktane","year":"2018","unstructured":"Jaunmuktane Z, Quaegebeur A, Taipa R, Viana-Baptista M, Barbosa R, Koriath C et al (2018) Evidence of amyloid-beta cerebral amyloid angiopathy transmission through neurosurgery. In: Acta Neuropathol"},{"key":"532_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-017-0442-8","volume":"5","author":"SK Kaufman","year":"2017","unstructured":"Kaufman SK, Thomas TL, Del Tredici K, Braak H, Diamond MI (2017) Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue. Acta Neuropathol Commun 5:41","journal-title":"Acta Neuropathol Commun"},{"issue":"Suppl 1","key":"532_CR30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","volume":"22","author":"T Konno","year":"2016","unstructured":"Konno T, Ross OA, Puschmann A, Dickson DW, Wszolek ZK (2016) Autosomal dominant Parkinson's disease caused by SNCA duplications. Parkinsonism Relat Disord 22(Suppl 1):S1\u2013S6","journal-title":"Parkinsonism Relat Disord"},{"key":"532_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ et al (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953","journal-title":"Science"},{"key":"532_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209:975\u2013986","journal-title":"J Exp Med"},{"key":"532_CR33","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815","journal-title":"J Neurosci"},{"key":"532_CR34","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.febslet.2006.02.032","volume":"580","author":"M Masuda","year":"2006","unstructured":"Masuda M, Dohmae N, Nonaka T, Oikawa T, Hisanaga S, Goedert M et al (2006) Cysteine misincorporation in bacterially expressed human alpha-synuclein. FEBS Lett 580:1775\u20131779","journal-title":"FEBS Lett"},{"key":"532_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H et al (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88","journal-title":"Acta Neuropathol Commun"},{"key":"532_CR36","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H et al (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136:1128\u20131138","journal-title":"Brain"},{"key":"532_CR37","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","volume":"33","author":"AL Mougenot","year":"2012","unstructured":"Mougenot AL, Nicot S, Bencsik A, Morignat E, Verchere J, Lakhdar L et al (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 33:2225\u20132228","journal-title":"Neurobiol Aging"},{"key":"532_CR38","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI200215777","volume":"110","author":"M Neumann","year":"2002","unstructured":"Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W et al (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110:1429\u20131439","journal-title":"J Clin Invest"},{"key":"532_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/bi0485528","volume":"44","author":"T Nonaka","year":"2005","unstructured":"Nonaka T, Iwatsubo T, Hasegawa M (2005) Ubiquitination of alpha-synuclein. Biochemistry 44:361\u2013368","journal-title":"Biochemistry"},{"key":"532_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T et al (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4:124\u2013134","journal-title":"Cell Rep"},{"key":"532_CR41","doi-asserted-by":"publisher","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","volume":"285","author":"T Nonaka","year":"2010","unstructured":"Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M (2010) Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 285:34885\u201334898","journal-title":"J Biol Chem"},{"key":"532_CR42","doi-asserted-by":"publisher","unstructured":"Nussbaum RL (2017) Genetics of Synucleinopathies. Cold Spring Harb Perspect Med. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a024109","DOI":"10.1101\/cshperspect.a024109"},{"key":"532_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M et al (2015) Alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"532_CR44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1128\/JVI.80.1.322-331.2006","volume":"80","author":"D Peretz","year":"2006","unstructured":"Peretz D, Supattapone S, Giles K, Vergara J, Freyman Y, Lessard P et al (2006) Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 80:322\u2013331","journal-title":"J Virol"},{"key":"532_CR45","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR46","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB et al (2015) Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 112:E5308\u2013E5317","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Perez-Villalba A et al (2014) Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75:351\u2013362","journal-title":"Ann Neurol"},{"key":"532_CR48","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW et al (2014) Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 111:10732\u201310737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M et al (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"532_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00401-014-1360-5","volume":"129","author":"M Schweighauser","year":"2015","unstructured":"Schweighauser M, Bacioglu M, Fritschi SK, Shimshek DR, Kahle PJ, Eisele YS et al (2015) Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts. Acta Neuropathol 129:157\u2013159","journal-title":"Acta Neuropathol"},{"key":"532_CR51","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","volume":"97","author":"LC Serpell","year":"2000","unstructured":"Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA (2000) Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A 97:4897\u20134902","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR52","doi-asserted-by":"publisher","first-page":"8896","DOI":"10.1074\/jbc.M115.713552","volume":"291","author":"S Shimonaka","year":"2016","unstructured":"Shimonaka S, Nonaka T, Suzuki G, Hisanaga S, Hasegawa M (2016) Templated aggregation of TAR DNA-binding protein of 43 kDa (TDP-43) by seeding with TDP-43 peptide fibrils. J Biol Chem 291:8896\u20138907","journal-title":"J Biol Chem"},{"key":"532_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","volume":"5","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M et al (2017) Propagation of pathological alpha-synuclein in marmoset brain. Acta Neuropathol Commun 5:12","journal-title":"Acta Neuropathol Commun"},{"key":"532_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208","journal-title":"Neurosci Lett"},{"key":"532_CR55","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95:6469\u20136473","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"532_CR57","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-015-1415-2","volume":"129","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Miyata H, Kametani F, Nonaka T, Akiyama H, Hisanaga S et al (2015) Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau. Acta Neuropathol 129:895\u2013907","journal-title":"Acta Neuropathol"},{"key":"532_CR58","doi-asserted-by":"publisher","first-page":"18675","DOI":"10.1074\/jbc.M116.734707","volume":"291","author":"A Tarutani","year":"2016","unstructured":"Tarutani A, Suzuki G, Shimozawa A, Nonaka T, Akiyama H, Hisanaga S et al (2016) The effect of fragmented pathogenic alpha-Synuclein seeds on prion-like propagation. J Biol Chem 291:18675\u201318688","journal-title":"J Biol Chem"},{"key":"532_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1348-0421.1991.tb01544.x","volume":"35","author":"J Tateishi","year":"1991","unstructured":"Tateishi J, Tashima T, Kitamoto T (1991) Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immunol 35:163\u2013166","journal-title":"Microbiol Immunol"},{"key":"532_CR60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40478-014-0151-5","volume":"2","author":"A Thomzig","year":"2014","unstructured":"Thomzig A, Wagenfuhr K, Daus ML, Joncic M, Schulz-Schaeffer WJ, Thanheiser M et al (2014) Decontamination of medical devices from pathological amyloid-beta-, tau- and alpha-synuclein aggregates. Acta Neuropathol Commun 2:151","journal-title":"Acta Neuropathol Commun"},{"key":"532_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180\u2013182","journal-title":"Neurosci Lett"},{"key":"532_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M (2015) Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci 38:87\u2013103","journal-title":"Annu Rev Neurosci"},{"key":"532_CR63","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM et al (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A 110:19555\u201319560","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR64","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B et al (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6:e1001217","journal-title":"PLoS Pathog"},{"key":"532_CR65","volume-title":"Acta Neuropathol","author":"AL Woerman","year":"2017","unstructured":"Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A et al (2017) MSA prions exhibit remarkable stability and resistance to inactivation. In: Acta Neuropathol"},{"key":"532_CR66","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","volume":"112","author":"AL Woerman","year":"2015","unstructured":"Woerman AL, Stohr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC et al (2015) Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci U S A 112:E4949\u2013E4958","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0532-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T19:34:57Z","timestamp":1555529697000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0532-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0532-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"29"}}